These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26068198)

  • 1. Enteric protection of naproxen in a fixed-dose combination product produced by hot-melt co-extrusion.
    Vynckier AK; De Beer M; Monteyne T; Voorspoels J; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2015 Aug; 491(1-2):243-9. PubMed ID: 26068198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and relative bioavailability of a fixed-dose combination of enteric-coated naproxen and non-enteric-coated esomeprazole magnesium.
    Wang-Smith L; Fort J; Zhang Y; Sostek M
    J Clin Pharmacol; 2012 May; 52(5):670-80. PubMed ID: 21628602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
    Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
    Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The manufacture and characterisation of hot-melt extruded enteric tablets.
    Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
    Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-extrusion as manufacturing technique for multilayer mini-matrices with dual drug release.
    Dierickx L; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1157-63. PubMed ID: 23422733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot-melt co-extrusion for the production of fixed-dose combination products with a controlled release ethylcellulose matrix core.
    Vynckier AK; Dierickx L; Saerens L; Voorspoels J; Gonnissen Y; De Beer T; Vervaet C; Remon JP
    Int J Pharm; 2014 Apr; 464(1-2):65-74. PubMed ID: 24486558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-extrusion as manufacturing technique for fixed-dose combination mini-matrices.
    Dierickx L; Saerens L; Almeida A; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Aug; 81(3):683-9. PubMed ID: 22504402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
    Cryer BL; Sostek MB; Fort JG; Svensson O; Hwang C; Hochberg MC
    Ann Med; 2011 Dec; 43(8):594-605. PubMed ID: 22017620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.
    Choi Y; Han H; Shin D; Lim KS; Yu KS
    Drug Des Devel Ther; 2015; 9():4127-35. PubMed ID: 26257511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
    Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
    Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-extrusion as a processing technique to manufacture a dual sustained release fixed-dose combination product.
    Vynckier AK; Voorspoels J; Remon JP; Vervaet C
    J Pharm Pharmacol; 2016 May; 68(5):721-7. PubMed ID: 26751978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-extruded solid solutions as immediate release fixed-dose combinations.
    Dierickx L; Van Snick B; Monteyne T; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2014 Oct; 88(2):502-9. PubMed ID: 25008213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of enteric coated tablets of hot-melt extruded lansoprazole.
    Alsulays BB; Kulkarni V; Alshehri SM; Almutairy BK; Ashour EA; Morott JT; Alshetaili AS; Park JB; Tiwari RV; Repka MA
    Drug Dev Ind Pharm; 2017 May; 43(5):789-796. PubMed ID: 27486807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation.
    Chawla A; Sharma P; Pawar P
    Acta Pharm; 2012 Dec; 62(4):529-45. PubMed ID: 23333888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
    Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G
    Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the interactions of enteric and hydrophilic polymers to enhance dissolution of griseofulvin following hot melt extrusion processing.
    Bennett RC; Keen JM; Bi YV; Porter S; Dürig T; McGinity JW
    J Pharm Pharmacol; 2015 Jul; 67(7):918-38. PubMed ID: 25645386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melt extrusion vs. spray drying: The effect of processing methods on crystalline content of naproxen-povidone formulations.
    Haser A; Cao T; Lubach J; Listro T; Acquarulo L; Zhang F
    Eur J Pharm Sci; 2017 May; 102():115-125. PubMed ID: 28259831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel naproxen/esomeprazole magnesium compound pellets based on acid-independent mechanism: in vitro and in vivo evaluation.
    Lu J; Kan S; Zhao Y; Zhang W; Liu J
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1495-503. PubMed ID: 26902772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.